晚期胃癌一线氟嘧啶联合铂类化疗的早期肿瘤免疫微环境重塑与疗效
本研究对初治HER2阳性与阴性晚期胃癌患者配对治疗前与治疗中样本进行全外显子测序、bulk RNA及单细胞转录组分析,定义与铂类化疗应答相关的特征。应答与治疗中NK细胞募集、肿瘤相关巨噬细胞减少、M1巨噬细胞复极化及效应T细胞浸润增加相关;非应答者见PD-L1低/缺失表达或调节、Wnt信号增加、B细胞浸润及表达LAG3的T细胞增加伴树突状细胞减少。早期治疗中采样未观察到显著基因组变化。
要点
- 应答者治疗中见NK细胞募集、肿瘤相关巨噬细胞减少、M1复极化及效应T细胞浸润增加。
- 非应答者见PD-L1低/缺失表达或调节、Wnt信号增加、B细胞浸润及LAG3表达T细胞增加伴树突状细胞减少。
- 早期治疗中采样未观察到显著基因组变化。
核心结论
- 研究提供标准化疗下治疗中肿瘤免疫微环境调控图谱,并提名未来候选方法。
研究设计与样本
- 对初治HER2阳性与HER2阴性晚期胃癌患者配对治疗前与治疗中样本进行全外显子测序、bulk RNA及单细胞转录组分析。
主要发现
- 应答与治疗中肿瘤免疫微环境重塑相关,包括NK细胞募集、肿瘤相关巨噬细胞减少、M1巨噬细胞复极化及效应T细胞浸润增加。
- 非应答者见PD-L1低/缺失表达或调节,治疗中Wnt信号增加、B细胞浸润及表达LAG3的T细胞增加伴树突状细胞减少。
- 早期治疗中采样未观察到显著基因组变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Chemotherapy is ubiquitous in first-line treatment of advanced gastric cancer, yet responses are heterogeneous, and little is known about mediators of chemotherapy response. To move forward, an understanding of the effects of standard chemotherapy on the tumor-immune microenvironment (TME) is needed. Coupling whole-exome sequencing, bulk RNA and single-cell transcriptomics from paired pretreatment and on-treatment samples in treatment-naïve patients with HER2-positive and HER2-negative gastric cancer, we define features associated with response to platinum-based chemotherapy. Response was associated with on-treatment TME remodeling including natural killer (NK) cell recruitment, decreased tumor-associated macrophages, M1-macrophage repolarization, and increased effector T-cell infiltration. Among chemotherapy nonresponders, we observed low/absent PD-L1 expression or modulation, on-treatment increases in Wnt signaling, B-cell infiltration, and LAG3-expressing T cells coupled to an exodus of dendritic cells. We did not observe significant genomic changes in early on-treatment sampling. We provide a map of on-treatment TME modulation with standard chemotherapy and nominate candidate future approaches. SIGNIFICANCE: Using paired pretreatment and on-treatment samples during standard first-line chemotherapy, we identify chemotherapy-induced NK-cell infiltration, macrophage repolarization, and increased antigen presentation among responders. Increased LAG3 expression and decreased dendritic cell abundance were seen in nonresponders, emphasizing remodeling of the TME during chemotherapy response and resistance. This article is highlighted in the In This Issue feature, p. 873.
引用
- Kim R, An M, Lee H, et al. Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer. Cancer Discov. 2022. PMID: 34933901. doi:10.1158/2159-8290.CD-21-0888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。